Anticoagulant and anticancer activities of Hirudo sulukii saliva extract (HSSE): Inhibition of thrombin and PI3K/AKT/mTOR signaling in prostate cancer cell lines
- 8 August 2026
- journal article
- Published by Elsevier in European Journal of Integrative Medicine
- Vol. 87
Abstract
No abstract availableFunding Information
- Erciyes Üniversitesi
- Bilimsel Araştırma Projeleri, Erciyes Üniversitesi (TSA-2024-13565)
This publication has 25 references indexed in Scilit:
- New anticoagulant protein from medicinal leechBiochemical and Biophysical Research Communications, 2024
- Mechanism of Hirudin-Mediated Inhibition of Proliferation in Ovarian Cancer CellsMolecular Biotechnology, 2024
- Development of Leech extract as a therapeutic agent: A chronological reviewPharmacological Research - Modern Chinese Medicine, 2024
- Comparison of body wall histologic structure of two medicinal leeches Hirudo sulukii and Hirudo verbana (Hirudinida: Hirudinidae)Cell and tissue research, 2021
- Production and Characterization of Hirudin Variant-1 by SUMO Fusion Technology in E. coliMolecular Biotechnology, 2012
- Small bite, large impact–saliva and salivary molecules in the medicinal leech, Hirudo medicinalisThe Science of Nature, 2011
- Akt, FoxO and regulation of apoptosisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Thrombin activation of PI3K/PDK1/Akt signaling promotes cyclin D1 upregulation and RPE cell proliferationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- In vitro cytotoxic screening of selected Saudi medicinal plantsJournal of Natural Medicines, 2011
- The role of cell adhesion molecules and proteases in tumor invasion and metastasisWorld Journal of Urology, 1996